Gemcitabine-Induced Pulmonary Toxicity in a Patient with Pancreatic Cancer

  • Daigo Hiraya Departments of Internal Medicine and Surgery, Mito Medical Center, University of Tsukuba. Mito, Ibaraki, Japan
  • Katsunori Kagohashi Departments of Internal Medicine and Surgery, Mito Medical Center, University of Tsukuba. Mito, Ibaraki, Japan
  • Naoya Sakamoto Departments of Internal Medicine and Surgery, Mito Medical Center, University of Tsukuba. Mito, Ibaraki, Japan
  • Tadashi Kondo Departments of Internal Medicine and Surgery, Mito Medical Center, University of Tsukuba. Mito, Ibaraki, Japan
  • Hiroaki Satoh Departments of Internal Medicine and Surgery, Mito Medical Center, University of Tsukuba. Mito, Ibaraki, Japan
DOI: https://doi.org/10.6092/1590-8577/3858
Keywords: Deoxycytidine /analogs and derivatives /toxicity, gemcitabine, Lung, Pancreatic Neoplasms

Abstract

No abstract available.

Image: Chest CT showing bilateral diffuse ground-glass opacities in both lungs.

Downloads

Download data is not yet available.

References

Shaib W, Lansigan F, Cornfeld D, Syrigos K, Saif MW. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. JOP. J Pancreas (Online) 2008; 9:708-14. [PMID 18981552] (FULL TEXT: http://www.joplink.net/prev/200811/07.html)

Briasoulis E, Pavlidis N. Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy. Oncologist 2001; 6:153-61. [PMID 11306727] (FULL TEXT: http://theoncologist.alphamedpress.org/cgi/content/full/6/2/153)

Roychowdhury DF, Cassidy CA, Peterson P, Arning M. A report on serious pulmonary toxicity associated with gemcitabine-based therapy. Invest New Drugs 2002; 20:311-5. [PMID 12201493] (FULL TEXT: http://www.springerlink.com/content/1ldp62up20rf6xqf/fulltext.pdf)

Vahid B, Marik PE. Pulmonary complications of novel antineoplastic agents for solid tumors. Chest 2008; 133:528-38. [PMID 18252919] (FULL TEXT: http://chestjournal.chestpubs.org/content/133/2/528.long)

Lawrence TS, Eisbruch A, Shewach DS. Gemcitabine-mediated radiosensitization. Semin Oncol 1997; 24(2 Suppl 7):S7-24-8. [PMID 9194476]

Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. Radiosensitization by gemcitabine. Oncology (Williston Park) 1995; 13(Suppl 5):55-60. [PMID 10550827]

Safran H, Dipetrillo T, Iannitti D, Quirk D, Akerman P, Cruff D, et al. Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial. Int J Radiat Oncol Biol Phys 2002; 54:137-41. [PMID 12182983] (FULL TEXT: http://www.redjournal.org/article/PIIS0360301602029024/fulltext)

Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80:286-91. [PMID 9217042] (FULL TEXT: http://www3.interscience.wiley.com/cgi-bin/fulltext/75502650/HTMLSTART)

Chest CT showing bilateral diffuse ground-glass opacities in both lungs
Published
2010-03-05
How to Cite
HirayaD., KagohashiK., SakamotoN., KondoT., & SatohH. (2010). Gemcitabine-Induced Pulmonary Toxicity in a Patient with Pancreatic Cancer. JOP. Journal of the Pancreas, 11(2), 186-188. https://doi.org/10.6092/1590-8577/3858
Issue
Vol 11 No 2 (2010): March - p. 95-198
Section
LETTERS

Copyright (c) 2010 Daigo Hiraya, Katsunori Kagohashi, Naoya Sakamoto, Tadashi Kondo, Hiroaki Satoh

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.